Zobrazeno 1 - 10
of 2 863
pro vyhledávání: '"hypertensive heart disease"'
Autor:
G. Domain, M. Biscond, N. Dognin, C. Strube, P. Mondoly, P. Réant, J.F. Sarrazin, M. Galinier, J. Champagne, A. Rollin, D. Carrié, H. Cochet, O. Lairez, F. Philippon, J. Ferrières, P. Maury, C. Steinberg
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3924-3933 (2024)
Abstract Aim The diagnosis of hypertrophic cardiomyopathy (HCM) with moderate hypertrophy is challenging. Hypertensive heart disease (HHD) is the most common differential diagnosis that mimics the LVH of HCM. The aim of this study was to compare the
Externí odkaz:
https://doaj.org/article/241b966a530f4f8f8540843c395e24bf
Autor:
Ze-Peng Ma, Shi-Wei Wang, Lin-Yan Xue, Xiao-Dan Zhang, Wei Zheng, Yong-Xia Zhao, Shuang-Rui Yuan, Gao-Yang Li, Ya-Nan Yu, Jia-Ning Wang, Tian-Le Zhang
Publikováno v:
BMC Medical Imaging, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The prevalence of hypertensive heart disease (HHD) is high and there is currently no easy way to detect early HHD. Explore the application of radiomics using cardiac magnetic resonance (CMR) non-enhanced cine sequences in diagnosi
Externí odkaz:
https://doaj.org/article/4e07ece431e14a01bd8a13ed1cb17370
Autor:
Qingyuan Zhao, Zhiyu Chen, Chengcheng Qi, Sunan Xu, Ruichen Ren, Wenting Li, Xiaoxue Zhang, Yang Zhang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionDifferentiating hypertensive heart disease (HHD) from hypertrophic cardiomyopathy (HCM) is crucial yet challenging due to overlapping clinical and morphological features. Recent studies have explored the use of various cardiac magnetic re
Externí odkaz:
https://doaj.org/article/bd19f5d48e17498c893a05b7d89e7de0
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundHypertensive heart disease (HHD) is a major global public health issue resulting from hypertension-induced end-organ damage. The aim of this study was to examine the global impact, risk factors, and age-period-cohort (APC) model of HHD from
Externí odkaz:
https://doaj.org/article/39cb9a6bb8e24503ae6d34e38fcdb9f2
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Aims Assessing the global burden and health inequalities of Hypertension Heart Disease (HHD) during the period from 1990 to 2019. Methods Secondary analysis of the Global Burden of Disease (GBD) study in 2019, focusing on the burden of disea
Externí odkaz:
https://doaj.org/article/6d4175d389aa4f66a9fdb934a651daee
Publikováno v:
Vascular Health and Risk Management, Vol Volume 19, Pp 789-796 (2023)
Konstantinos Vasileiadis, Christina Antza, Vasilios Kotsis Hypertension Center, 3rd Department of Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence: Vasilios Kotsis, Hypertension-ABPM Center, Pa
Externí odkaz:
https://doaj.org/article/ade2c1fab6a74492bc7294969010f87e
Publikováno v:
Archives of Medical Science, Vol 19, Iss 5, Pp 1186-1200 (2023)
Introduction No survey has evaluated hypertensive heart disease (HHD) burden with statistics from the Risk Factors Study, Injuries, and the Global Burden of Diseases (GBD) 2019. Material and methods The evaluated annual percentage changes (EAPCs) we
Externí odkaz:
https://doaj.org/article/e00f5723a7ee4046a491f89e81f4961e
Publikováno v:
Heliyon, Vol 9, Iss 12, Pp e22671- (2023)
Aim: This study aimed to describe the prevalence, deaths, and disability-adjusted life-years (DALYs) of hypertensive heart disease (HHD) at the global, regional, and national levels and analyze epidemiological trends. Method: We extracted global esti
Externí odkaz:
https://doaj.org/article/597bb4b3c6dc4d5b870ae28975ce409d
Autor:
Vivian Lee, Qishi Zheng, Desiree-Faye Toh, Chee Jian Pua, Jennifer A. Bryant, Chi-Hang Lee, Stuart A. Cook, Javed Butler, Javier Díez, A. Mark Richards, Thu-Thao Le, Calvin W. L. Chin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundDiffuse interstitial myocardial fibrosis is a key common pathological manifestation in hypertensive heart disease (HHD) progressing to heart failure (HF). Angiotensin receptor–neprilysin inhibitors (ARNi), now a front-line treatment for H
Externí odkaz:
https://doaj.org/article/1b177e2affe24770b9f07cf919337730
Autor:
Peter Stanko, Kristina Repova, Tomas Baka, Kristina Krajcirovicova, Silvia Aziriova, Andrej Barta, Stefan Zorad, Michaela Adamcova, Fedor Simko
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 733 (2024)
There is ample evidence on the benefit of angiotensin receptor-neprilysin inhibitors (ARNIs) in heart failure, yet data regarding the potential protective action of ARNIs in hypertensive heart disease are sparse. The aim of this study was to show whe
Externí odkaz:
https://doaj.org/article/0368537847cb401895ba76752ec9565e